-The Hindu Study says 10 per cent of Rajasthan's population migrates seasonally in search of work Jaipur: As many as 5.79 million people in Rajasthan, or 10 per cent of the State's population, migrates seasonally in search of employment, says a new study on migration and labour. Approximately 4.38 million households thus send a person or more to other States in search of work seasonally, it adds. The number of migrants per household...
More »SEARCH RESULT
Mala Fide Decision on Drug Prices
-Economic and Political Weekly The decision to reduce the powers of the drug pricing body goes against the interest of public health. The decision of the Government of India to withdraw the power of the National Pharmaceutical Pricing Authority (NPPA) to set price controls on drugs that are not on the National List of Essential Medicines (NLEM) raises questions on the Narendra Modi regime's commitment to people's welfare. One must ask if...
More »Organic agri production rises in State
-The Pioneer Bhopal (Madhya Pradesh): As a result of the State Government's tireless efforts to promote organic farming in Madhya Pradesh, organic agriculture production in the State has risen to 5 lakh MT, about 40 per cent of country's total production. Cotton, wheat, foodgrains, fruits and vegetables are mainly produced through organic farming in the State. A study by industry body, Asshocham, said that MP has the potential to produce wealth of `23,000...
More »Drug price reins off before Modi’s US trip -GS Mudur
-The Telegraph New Delhi: A government agency has blocked its own pledge to impose price control on more medicines by withdrawing guidelines that it had used in July this year to cap prices of drugs used to treat diabetes and cardiovascular diseases. The National Pharmaceutical Pricing Authority (NPPA) has withdrawn the guidelines issued under Paragraph 19 of the Drug Price Control Order that it had used in July this year to cap...
More »Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee
-The Times of India MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a...
More »